Combatting the rise of antimicrobial resistance Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as…martin01.11.2023
AMR Action Fund invests in new antibiotics developed by BioVersys The AMR Action Fund has made its first European investment in BioVersys, which is headquartered…martin01.06.2023
Investors give Resistell 8.5 million Swiss francs Resistell AG has secured 8.5 million Swiss francs in the first part of its series…martin12.23.2022
South Korean pharma firms show interest in the Basel Area Several South Korean firms from the life sciences industry, including three pharmaceutical multinationals, have visited…martin11.28.2022
Databaum establishes headquarters in Basel Databaum is establishing its headquarters in Basel and plans to grow from its location there.…martin11.14.2022
Clinerion launches patient information platform Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals…martin11.10.2022
New innovation campus opens in the Basel Area The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October…martin10.29.2022
Sumitovant acquires all shares in Myovant Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by…martin10.24.2022
VectivBio raises 125 million US dollars in stock sale VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The Basel-based…martin10.21.2022
KetoSwiss secures capital increase of 4 million dollars KetoSwiss has banked a total of 4 million US dollars from investors. The Basel-based startup…martin10.14.2022